Finance

AstraZeneca Posts Solid Q4 Earnings, Shares Rally Near 52-Week High

Strong oncology sales and positive outlook drive investor confidence in 2026 growth prospects

AstraZeneca Plc reported fourth-quarter 2025 revenue of $15.50 billion, slightly above expectations, with adjusted earnings per share exceeding estima...

Evommune Shares Surge Amid Positive Phase 2a Data for Atopic Dermatitis Treatment

Clinical trial results for EVO301 drive significant investor interest despite mixed technical signals

Evommune, Inc. witnessed a sharp increase in its stock price following the release of encouraging top-line data from its Phase 2a clinical study asses...

Moderna and Mexican Government Collaborate to Expand Local mRNA Vaccine Production

Strategic agreement aims to enhance domestic manufacturing and bolster pandemic responsiveness in Mexico

Moderna Inc. has entered into a long-term strategic partnership with the Mexican government to develop and strengthen local mRNA vaccine production ca...

Eddie Bauer Seeks Chapter 11 Protection Amid Rising Tariff and Inflation Challenges

Tariff uncertainty and operational costs drive Seattle outdoor apparel brand into restructuring with lender support

Eddie Bauer LLC has filed for voluntary Chapter 11 bankruptcy protection in the District of New Jersey amidst increasing tariffs and inflationary pres...

Nebius Strengthens AI Platform with Tavily Acquisition

Strategic Purchase Aims to Accelerate Development of Autonomous AI Agents

Nebius Group is advancing its artificial intelligence capabilities by acquiring Tavily, an agentic search technology provider. This move integrates re...

Analysts Adjust Forecasts After Pagaya Technologies’ Q4 Earnings and Lowered Guidance

Mixed quarterly results and cautious outlook prompt cuts in price targets by leading research firms

Pagaya Technologies Ltd. released its fourth-quarter financial results showing earnings per share surpassing estimates but sales falling short. The co...

Edgewell Personal Care Sees Mixed Q1 Results, Analysts Lift Price Targets

Adjusted EPS beats expectations despite sales shortfall; FY2026 earnings guidance revised downward while sales outlook remains steady

Edgewell Personal Care Company reported a mixed financial performance for the first quarter, delivering adjusted earnings per share (EPS) ahead of mar...

Upwork's Q4 Earnings Prompt Mixed Analyst Price Target Adjustments Amid Revenue Beat

Despite surpassing quarterly expectations, Upwork's guidance for Q1 and full-year 2026 elicits cautious revisions from market analysts

Upwork Inc announced Q4 2025 financial results exceeding analyst revenue and earnings predictions, which were contrasted by tempered first-quarter and...

Coca-Cola Company Delivers Steady Growth Amid Leadership Transition and Market Challenges in Q4 2025

Fourth-quarter results show consistent revenue increase, strategic portfolio expansion, and a focus on innovation as new CEO takes helm

The Coca-Cola Company reported its financial results for the fourth quarter of 2025, highlighting stable organic revenue growth, positive volume momen...

Nektar Therapeutics Shares Surge on Strong Atopic Dermatitis Trial Data

Positive outcomes from a pivotal study propel NKTR stock sharply higher amid healthcare sector sluggishness

Nektar Therapeutics' stock experienced a significant gain following the release of positive 36-week data from the REZOLVE-AD clinical trial evaluating...

Microbot Medical and IDEX Corp Initiate Coverage with Positive Outlooks

Analyst Initiations Highlight Microbot Medical's Bullish Potential and IDEX Corp's Market Momentum

Recent analyst coverage has begun on Microbot Medical Inc and IDEX Corp, with promising initial evaluations suggesting bullish prospects for the forme...

DuPont Reports Stable Q4 Sales with Strong Earnings Beat, Shares React Positively

Despite Slight Organic Sales Decline, DuPont's Earnings and Cash Flow Impress Investors

DuPont de Nemours, Inc. released its quarterly and full-year financial results showing steady sales and improved profitability in 2025. Although organ...